NRMI and current treatment patterns for ST-elevation myocardial infarction

This publication has 9 references indexed in Scilit:

• The problem of underdosing of angiotensin-converting enzyme inhibitors is markedly overrated: results from a study of patients discharged from hospital after an acute myocardial infarction
  European Journal of Clinical Pharmacology, 2004
• Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?
  The American Journal of Cardiology, 2003
• A Comparison of Coronary Angioplasty with Fibrinolytic Therapy in Acute Myocardial Infarction
  New England Journal of Medicine, 2003
• Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the thrombolysis in myocardial infarction trials
  Journal of the American College of Cardiology, 2003
• Magnitude and impact of after hours treatment delay in patients undergoing primary angioplasty for acute myocardial infarction: The CADILLAC Trial
  Journal of the American College of Cardiology, 2003
• Relationship between time-to-reperfusion and 30-day mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty
  Journal of the American College of Cardiology, 2003
• Relationship of Symptom-Onset-to-Balloon Time and Door-to-Balloon Time With Mortality in Patients Undergoing Angioplasty for Acute Myocardial Infarction
  JAMA, 2000
• Effect of Beta-Blockade on Mortality among High-Risk and Low-Risk Patients after Myocardial Infarction
  New England Journal of Medicine, 1998
• Use of Reperfusion Therapy for Acute Myocardial Infarction in the United States
  Circulation, 1998